Touyun Biotech Publishes 22 Apr 2026 AGM Circular and Outlines Shareholder Communication Options

Bulletin Express
Apr 22

Touyun Biotech Group Limited released its latest corporate communication package on 22 April 2026. The package comprises the circular for the upcoming Annual General Meeting (AGM), the AGM notice and the proxy form.

The full English and Chinese versions are now available on both the company’s website (www.touyunbiotech.com.hk) and HKEx’s website (www.hkexnews.hk). Registered shareholders are encouraged to access these documents online.

Shareholders who have previously elected to receive printed copies will find the current circular enclosed with the letter. Those who experience difficulties accessing the online documents, or who prefer hard copies of future communications, may submit a signed reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label provided, or email 1332-ecom@vistra.com. Printed materials will be dispatched free of charge upon request.

The company stresses that shareholders are responsible for maintaining a functional email address. Without a valid email on record, Touyun Biotech can only send notices of publication and actionable communications in printed form until an updated email address is supplied.

For enquiries, shareholders can call Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).

The notification is signed by Chairman Wang Liang on behalf of Touyun Biotech Group Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10